Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Proteomics is a new enabling technology that is being integrated into the drug discovery process. This will facilitate the systematic analysis of proteins across any biological system or disease, forwarding new targets and information on mode of action, toxicology and surrogate markers. Proteomics is highly complementary to genomic approaches in the drug discovery process and, for the first time, offers scientists the ability to integrate information from the genome, expressed mRNAs, their respective proteins and subcellular localization. It is expected that this will lead to important new insights into disease mechanisms and improved drug discovery strategies to produce novel therapeutics.

Original publication

DOI

10.1016/s1359-6446(98)01291-4

Type

Journal article

Journal

Drug discovery today

Publication Date

02/1999

Volume

4

Pages

55 - 62

Addresses

Oxford GlycoSciences, 10 The Quadrant, Abingdon Science Park, Abingdon, Oxfordshire, UK OX14 3YS.